Licaminlimab

Licaminlimab (OCS-02) is a single-chain anti-TNF alpha antibody fragment. TNF alpha is an inflammatory cytokine produced by macrophages and monocytes during inflammation[1].

Product Specifications

CAS Number

[1688648-13-6]

Product Name Alternative

OCS-02

UNSPSC

12352203

Target

TNF Receptor

Type

Inhibitory Antibodies

Related Pathways

Apoptosis

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/licaminlimab.html

Purity

96.10

Solubility

10 mM in DMSO

Smiles

[Licaminlimab]

Molecular Weight

(26.74 kDa)

References & Citations

[1]Shettle L, et al. Topical Anti-TNFα Agent Licaminlimab (OCS-02) Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study. Clin Ophthalmol. 2022 Jul 6;16:2167-2177.